Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filgrastim vs Lenograstim for Stem Cell Mobilization in Multiple Myeloma
NCT00932217Phase 3Unknown
- Sponsor
- University of Pisa
- Start
- Dec 2004
- Primary completion
- Apr 2007
- Modality
- Cytokines & Interferons
01
Overview
Phase 3, randomised, open-label trial of filgrastim and lenograstim in multiple myeloma (MM), sponsored by University of Pisa. Status: unknown.
02
Drugs
filgrastimlenograstim
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00932217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00932217.